Table 2. Adverse event and survival ratios with MACH index for drug/comparator pairs.
Drug/Comparator | Adverse Events | Adverse Event ratio | Survival (mo) | Survival ratio | MACH Index |
---|---|---|---|---|---|
Bortezomib | 0.75 | 1.25 | 29.8 | 1.26 | 0.99 |
Dexamethasone | 0.60 | 23.7 | |||
Sunitinib | 0.37 | 1.48 | 26.0 | 1.30 | 1.14 |
Interferon alpha | 0.25 | 20.0 | |||
Regorafenib | 0.54 | 3.86 | 6.40 | 1.28 | 3.02 |
Placebo | 0.14 | 5.00 | |||
Sorafenib | 0.11 | 2.06 | 10.7 | 1.28 | 1.62 |
Placebo | 0.05 | 7.9 | |||
Erlotinib | 0.65 | 1.12 | 12.3 | 1.11 | 1.01 |
Placebo | 0.58 | 11.1 |